Comprehensive assessment of association between TLR4 gene polymorphisms and cancer risk: a systematic meta-analysis
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1087 views | HTML 1772 views | ?
Lu Ding1, Qifeng Jiang1, Guang Li1, Jia Shen1, Jiayin Du1, Xiaochen Lu1 and Xingliang Xiong1
1Department of Medical Informatics, Chongqing Medical University, Chongqing, 400016, China
Xingliang Xiong, email: [email protected]
Keywords: cancer risk, toll-like receptor, TLR4, SNP, meta-analysis
Received: July 18, 2017 Accepted: September 25, 2017 Published: October 06, 2017
Previous studies have explored the association between toll-like receptor 4 (TLR4) polymorphisms and risk of various cancers, but the results remained controversial. To obtain an assessment of the effect of TLR4 polymorphisms (rs4986790, rs4986791 and rs11536889) on cancer risk, fifty-five articles (containing 20107 cases and 28244 controls) were recruited for meta-analysis. Our result indicated that two Single Nucleotide Polymorphisms (SNP) in TLR4 were associated with decreased cancer risk for rs4986791: OR = 0.764, 95% CI: 0.652-0.894, P = 0.001 in allele model; OR = 0.769, 95%CI: 0.650-0.909, P = 0.002 in recessive model; OR = 0.505, 95% CI: 0.352-0.726, P = 0.000 in dominant model; for 11536889: OR = 0.927, 95% CI: 0.872–0.984, P = 0.013 in allele model; OR = 0.926, 95% CI: 0.862–0.944,P = 0.034 in recessive model. In terms of subgroup analyses sorted by ethnicity, only polymorphism of rs4986791 had a significant influence on decrease of cancer risk among both Caucasian and Asian populations. The findings suggested that TLR4 polymorphisms may serve as a genetic risk factor for cancers.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.